HopeStage
Back to all studies
Not Yet RecruitingNCT07456930

Real-World Evaluation of Compl-AI for Predicting Early Medication Dropout in Addiction Treatment

Observational studyAges 18+United States
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
San Diego and 1 more locationSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: June 1, 2027
Recruitment status
Not Yet Recruiting
Enrollment listed in the registry
295
Sponsor
Tools4Patient
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
Interview / survey / observational
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT07456930
Official title
Show the full official title

Real-World Assessment of Compl-AI in Predicting Early Discontinuation of Medication for Treatment of Opioid Use Disorder (MOUD) in Community and Specialty Treatment Programs

Recruitment & locations

Not yet recruiting

San Diego · Vista

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Tools4Patient.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as not yet recruiting.

Want to explore more studies?

Explore studies